Effective, low‑side‑effect cancer treatment in Iran using indigenous electrochemotherapy device

Pars Today — Innovators at one of Iran’s leading knowledge‑based biomedical technology companies have successfully developed an electroporation and electrochemotherapy device designed for effective cancer treatment with minimal side effects.

Using the expertise and experience of Iranian researchers and engineers, the team designed and built advanced electroporation and electrochemotherapy systems with dedicated therapeutic protocols. 

This achievement can play a significant role in expanding minimally invasive and targeted treatment methods for both human and veterinary medicine.

According to Pars Today, citing the IRIB News Agency, the Iranian company is now recognized as one of the few manufacturers of this advanced technology worldwide.

Amineh Mohammadi‑Moghaddam, head of the R&D department at the knowledge‑based company, described the locally produced electroporation device as one of the key technologies in modern medical research and treatment, saying: 

 “The device has been supplied to reputable scientific, academic, medical, and pharmaceutical centers across Iran, and is already being used in their research and clinical projects.”

Mohammadi‑Moghaddam added that the electroporation device is used in various fields such as biologic and recombinant drug production, genetically modified plant generation, genetic engineering, gene therapy, and cell therapy.

Speaking about countries that produce this technology and the competitive advantages of the domestic product, she explained: “Electroporation devices are currently manufactured in several countries — Europe, the United States, South Korea, Japan, and others — but domestic production based on local knowledge offers easier access, after‑sales service, and the development of treatment protocols tailored to Iran’s clinical needs.”